Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
Mai F. Tolba,
Mai F. Tolba,
Cesar A. Santa-Maria,
Adriana Albini,
Emile R. Chimusa,
Basel K. Al-Ramadi,
Basel K. Al-Ramadi,
Sara M. Tolaney,
Sara M. Tolaney
Affiliations
Mai F. Tolba
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt
Mai F. Tolba
School of Life and Medical Sciences, University of Hertfordshire Hosted by Global Academic Foundation (GAF), New Administrative Capital, Cairo, Egypt
Cesar A. Santa-Maria
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, Baltimore, MD, United States
Adriana Albini
Laboratory of Vascular Biology and Angiogenesis, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) MultiMedica, Milan, Italy
Emile R. Chimusa
Division of Human Genetics, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa
Basel K. Al-Ramadi
Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
Basel K. Al-Ramadi
Zayed Center for Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
Sara M. Tolaney
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
Sara M. Tolaney
Department of Medicine, Harvard Medical School, Boston, MA, United States
